{
  "resourceType": "RegulatedAuthorization",
  "id": "Altermol-500mg30mg-Tablet-SE-IS-RegulatedAuthorization",
  "meta": {
    "profile": [
      "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
    ]
  },
  "type": {
    "coding": [
      {
        "system": "https://spor.ema.europa.eu/v1/lists/220000000060",
        "code": "220000000061",
        "display": "Marketing Authorisation"
      }
    ]
  },
  "identifier": [
    {
      "system": "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
      "value": "50802"
    }
  ],
  "subject": [
    {
      "reference": "MedicinalProductDefinition/Altermol-500mg30mg-Tablet-SE-IS-MedicinalProductDefinition"
    }
  ],
  "region": [
    {
      "coding": [
        {
          "code": "100000000535",
          "system": "https://spor.ema.europa.eu/v1/lists/100000000002",
          "display": "Sweden"
        }
      ]
    }
  ],
  "status": {
    "coding": [
      {
        "code": "100000072099",
        "system": "https://spor.ema.europa.eu/v1/lists/100000072049",
        "display": "Valid"
      }
    ]
  },
  "statusDate": "2015-11-12",
  "case": {
    "type": {
      "coding": [
        {
          "code": "dateOfFirstAuthorisation",
          "system": "https://ema.europa.eu/fhir/authorisationDateType",
          "display": "First Authorisation"
        }
      ]
    },
    "dateDateTime": "2015-11-12"
  },
  "holder": {
    "reference": "Organization/LOC-100001100"
  }
}
